【摘要】 肥胖和食物成瘾已经成为危害人民群众健康的重要因素,其交互作用加剧代谢异常及并发症风险。胰高血糖素样肽-1受体激动剂(GLP-1RA)已成为治疗肥胖和食物成瘾的有利选择,其治疗机制也逐渐成为研究的热点和重点。研究表明,GLP-1RA通过中枢与外周机制抑制食欲、延缓胃排空,并作用于中脑边缘多巴胺系统,减少伏隔核多巴胺释放,削弱高热量食物的奖赏效应,从而改善食物成瘾行为,进一步治疗肥胖。然而,GLP-1RA的胃肠道不良反应及潜在长期风险仍需谨慎管理。文章就GLP-1RA治疗肥胖以及食物成瘾的临床研究进展进行综述,为肥胖和食物成瘾的药物选择提供参考。
【关键词】 胰高血糖素样肽-1受体激动剂;肥胖;食物成瘾;中脑边缘多巴胺系统
Mechanism of glucagon-like peptide-1 receptor agonist in the treatment of obesity and food addiction
LIU Luyao, LI Linwei, WANG Chen, DI Jianzhong
(Department of Weight Loss and Metabolism, Shanghai Sixth People’ s Hospital, Shanghai 201306, China)
Corresponding author: DI Jianzhong, E-mail: dijianzhong@stju.edu.cn
【Abstract】 Obesity and food addiction have become major threats to public health, and their synergistic interactions exacerbate metabolic abnormalities and comorbidities. Glucagon-like peptide-1 receptor agonist (GLP-1RA) has emerged as a promising therapeutic option for these conditions, and their mechanism of action has become a major research focus. Evidence indicates that GLP-1RA suppress appetite and delay gastric emptying through central and peripheral pathways. Furthermore, they modulate mesolimbic dopamine system (MLDS), reduce the release of dopamine in the nucleus accumben, attenuate the rewarding effects of high-calorie foods and ameliorate addictive eating behaviors, thereby treating obesity. However, adverse gastrointestinal effects and potential long-term risks of GLP-1RA necessitate cautious clinical management. In this article, recent clinical advances in the application of GLP-1RA applications for the treatment of obesity and food addiction were reviewed, providing reference for drug selection for obesity and food addiction.
【Key words】 GLP-1RA; Obesity; Food addiction; Mesolimbic dopamine system
肥胖已经成为危害人民健康的重要因素之一,根据世界肥胖联合会2023年发布的《世界肥胖地图》,预计到2035年全球将有超过40亿人肥胖或超重,占全球人口的51%[1]。肥胖分为原发性肥胖和继发性肥胖[2],当患者体质量指数(body mass index,BMI)超过40 kg/m2时,即为“病态肥胖”。这类患者的身体代谢功能严重失衡,将面临心血管疾病、糖尿病、骨关节病变等多种并发症的升高风险[3]。肥胖与多种代谢性疾病及心血管疾病密切相关:在代谢性疾病方面,肥胖增加了2型糖尿病患病风险;在心血管系统损害中,肥胖可诱发动脉粥样硬化(atherosclerosis,AS)、心力衰竭(heart failure,HF)、心房颤动(atrial fibrillation,AF)[4]等病理改变。此外,长期代谢紊乱还会导致糖尿病心肌病(diabetic cardiomyopathy,DCM)等特异性器官损伤。食物成瘾(food addiction,FA)是肥胖的危险因素和流行的关键原因之一,研究揭示在实施减重手术的肥胖患者中,约有1/3存在食物成瘾现象,并且患者的BMI越高,越易出现食物成瘾[5]。……